U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07106814) titled 'Safety and Efficacy of Metabolically Armed Tumor-lnfiltrating Lymphocytes(Meta 10-TIL)for the Treatment of Advanced Solid Tumors' on July 30.
Brief Summary: A Study of Metabolically Armed Tumor-Infiltrating Lymphocytes (Meta10-TIL) Therapy for Patients With Advanced Solid Tumors
Study Start Date: Aug. 15
Study Type: INTERVENTIONAL
Condition:
Advanced Solid Tumors
Intervention:
DRUG: Metabolically Armed TIL cells
Each subject receive metabolically armed TIL cells by intravenous infusion.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Anhui Provincial Hospital
Disclaimer: Curated by HT Syndication....